MolGraph
CompoundsDocumentationComplianceAbout
MolGraph

Research chemical sourcing and molecular building block RFQ workflows.

MolGraph is operated by Tessorix Inc.

support@molgraph.com

Products are intended for laboratory research use only and are not for human or veterinary use.

Compounds

  • Compound catalog
  • CAS Search

Company

  • About
  • Contact

Documentation

  • Quality Documentation
  • SDS Disclaimer

Compliance

  • Compliance

Legal

  • Terms
  • Privacy

Copyright © 2026 MolGraph. All Rights Reserved.

Home/Compounds/CAS 871700-17-3
Formula C26H23FIN5O4MW 615.4Research-use catalog entryCOA/SDS by request

Trametinib

CAS Number: 871700-17-3

Sourcing & RFQ

Submit an RFQ to review pricing, availability, lead time, pack size, purity, COA, and supplier SDS for this catalog entry.

Available options

Available Options

Package
1 g
Purity
98%
Price
Request review
Availability
Shipping review required
Delivery
Shipping review required
Package
1 mg
Purity
98%
Price
Request review
Availability
Shipping review required
Delivery
Shipping review required
Package
10 g
Purity
98%
Price
Request review
Availability
Shipping review required
Delivery
Shipping review required
Package
10 mg
Purity
98%
Price
Request review
Availability
Shipping review required
Delivery
Shipping review required
Package
100 mg
Purity
98%
Price
Request review
Availability
Shipping review required
Delivery
Shipping review required
Package
250 mg
Purity
98%
Price
Request review
Availability
Shipping review required
Delivery
Shipping review required
Package
5 g
Purity
98%
Price
Request review
Availability
Shipping review required
Delivery
Shipping review required
Package
50 mg
Purity
98%
Price
Request review
Availability
Shipping review required
Delivery
Shipping review required

Shipping review is required before pricing or stock can be confirmed publicly. Shipping, duties, and documentation fees are confirmed before order acceptance.

Loading RDKit molecule structure...
InChIKey: LIRYPHYGHXZJBZ-UHFFFAOYSA-NC26H23FIN5O4 | MW 615.4

Chemical Absolute Identifiers

CAS Number

871700-17-3

PubChem CID

11707110

Molecular Formula

C26H23FIN5O4

Molecular Weight

615.4 g/mol

Exact Mass

615.07788

InChIKey

LIRYPHYGHXZJBZ-UHFFFAOYSA-N

IUPAC Name

N-[3-[3-cyclopropyl-5-(2-fluoro-4-iodoanilino)-6,8-dimethyl-2,4,7-trioxopyrido[4,3-d]pyrimidin-1-yl]phenyl]acetamide

SMILES String

CC(=O)Nc1cccc(-n2c(=O)n(C3CC3)c(=O)c3c(Nc4ccc(I)cc4F)n(C)c(=O)c(C)c32)c1

Physical Properties

Water Solubility

1 mol/L

Properties are provided as catalog reference data and may be confirmed through supplier documentation when required.

Catalog Facts

Structural features

Trametinib (CAS 871700-17-3) is listed in the Advanced Chemicals portfolio, with molecular formula C26H23FIN5O4 and molecular weight 615. 40 g/mol.

Sourcing context

Catalog reference for RFQ preparation, supplier confirmation, and research chemical sourcing review.

Research use context

Intended for research building-block and synthetic chemistry workflows; structure-derived tags include nitrogen-containing heterocycle.

Documentation needs

COA/SDS status, availability, lead time, pack size, and shipment documentation can be confirmed during quotation.

Applications & Classification

Heterocyclic Building BlocksSynthetic ChemistryResearch intermediateCustom synthesis building blockResearch chemical sourcingCustom synthesis and catalog availability reviewCOA, SDS, pricing, and fulfillment workflow
Biological target reference

ChEMBL reports experimental activity evidence for: Dual specificity mitogen-activated protein kinase kinase 1 (Homo sapiens) — 20 assays; Dual specificity mitogen-activated protein kinase kinase 2 (Homo sapiens) — 18 assays; Mitogen-activated protein kinase 1 (Homo sapiens) — 4 assays; Tyrosine-protein kinase ABL1 (Homo sapiens) — 4 assays; Aurora kinase A (Homo sapiens) — 3 assays. These records describe research assays and do not establish therapeutic efficacy or clinical use.

Dual specificity mitogen-activated protein kinase kinase 1

Homo sapiens · SINGLE PROTEIN · 20 qualifying assays · 8 documents · best pChEMBL 9.32

Experimental evidence source: ChEMBL

Dual specificity mitogen-activated protein kinase kinase 2

Homo sapiens · SINGLE PROTEIN · 18 qualifying assays · 7 documents · best pChEMBL 9.32

Experimental evidence source: ChEMBL

Mitogen-activated protein kinase 1

Homo sapiens · SINGLE PROTEIN · 4 qualifying assays · 3 documents

Experimental evidence source: ChEMBL

Tyrosine-protein kinase ABL1

Homo sapiens · SINGLE PROTEIN · 4 qualifying assays · 3 documents

Experimental evidence source: ChEMBL

Aurora kinase A

Homo sapiens · SINGLE PROTEIN · 3 qualifying assays · 3 documents

Experimental evidence source: ChEMBL

Safety & Handling

Safety and handling reference content is available through documentation requests.

For supplier-issued SDS, request documentation before handling, storage, shipment, or procurement decisions.

Preliminary Safety Reference

For supplier-issued SDS or COA, submit a documentation request.

Safety Reference / SDS Request

Names & Synonyms / External Identifiers

Chemical Name

Trametinib

Names & Synonyms

JTP 74057GSK 1120212trametinibumN-(3-(3-cyclopropyl-5-((2-fluoro-4-iodophenyl)amino)-6,8-dimethyl-2,4,7-trioxo-3,4,6,7-tetrahydropyrido[4,3-d]pyrimidin-1(2H)-yl)phenyl)acetamideN-(3-{3-cyclopropyl-5-[(2-fluoro-4-iodophenyl)amino]-6,8-dimethyl-2,4,7-trioxo-3,4,6,7-tetrahydropyrido[4,3-d]pyrimidin-1(2H)-yl}phenyl)acetamide
Show all synonyms
Acetamide, N-[3-[3-cyclopropyl-5-[(2-fluoro-4-iodophenyl)amino]-3,4,6,7-tetrahydro-6,8-dimethyl-2,4,7-trioxopyrido[4,3-d]pyrimidin-1(2H)-yl]phenyl]-N-(3-{3-cyclopropyl-5-[(2-fluoro-4-iodophenyl)amino]-6,8-dimethyl-2,4,7-trioxo-1H,2H,3H,4H,6H,7H-pyrido[4,3-d]pyrimidin-1-yl}phenyl)acetamideAcetamide, N-(3-(3-cyclopropyl-5-((2-fluoro-4-iodophenyl)amino)-3,4,6,7-tetrahydro-6,8-dimethyl-2,4,7-trioxopyrido(4,3-d)pyrimidin-1(2H)-yl)phenyl)-N-(3-(3-cyclopropyl-5-((2-fluoro-4-iodophenyl)amino)-6,8-dimethyl-2,4,7-trioxo-1H,2H,3H,4H,6H,7H-pyrido(4,3-d)pyrimidin-1-yl)phenyl)acetamideN-(3-(3-CYCLOPROPYL-5-((2-FLUORO-4-IODOPHENYL)AMINO)-6,8-DIMETHYL-2,4,7-TRIOXO-3,4,6,7-TETRAHYDROPYRIDO(4,3-D)PYRIMIDIN-1(2H)-YL)PHENYL)ACETAMIDEN-(3-(3-cyclopropyl-5-((2-fluoro-4-iodophenyl)amino)-6,8-dimethyl-2,4,7-trioxopyrido(3,4-e)pyrimidin-1-yl)phenyl)acetamideN-[3-[3-Cyclopropyl-5-[(2-fluoro-4-iodophenyl)amino]-6,8-dimethyl-2,4,7-trioxo-3,4,6,7-tetrahydropyrido[4,3-d]pyrimidin-1(2H)-yl]phenyl]acetamideN-[3-[3-cyclopropyl-5-[(2-fluoro-4-iodophenyl)amino]-6,8-dimethyl-2,4,7-trioxopyrido[3,4-e]pyrimidin-1-yl]phenyl]acetamideMEK Inhibitor GSK1120212MekinistTrametinib (GSK1120212)N-[3-[3-Cyclopropyl-5-[(2-fluoro-4-iodophenyl)amino]-3,4,6,7-tetrahydro-6,8-dimethyl-2,4,7-trioxopyrido[4,3-d]pyrimidin-1(2H)-yl]phenyl]acetamideTrametinib [USAN]Trametinib (USAN)
External Identifiers
EC NUMBER: 629-899-3DSSTOX SUBSTANCE ID: DTXSID901007381CHEMBL ID: CHEMBL2103875CHEBI ID: CHEBI:75998UNII: 33E86K87QNDRUGBANK ID: DB08911KEGG ID: D10175METABOLOMICS WORKBENCH ID: 151997NCI THESAURUS CODE: C77908PHARMGKB ID: PA166115364RXCUI: 1425099WIKIDATA ID: Q7833138
Literature & Patent References
DOI 10.1021/acs.jmedchem.4c02662Discovery of INCB159020, an Orally Bioavailable KRAS G12D Inhibitor.PMID 39772605Discovery of INCB159020, an Orally Bioavailable KRAS G12D Inhibitor.DOI 10.1016/j.bmc.2023.117561Discovery of pyrazolo[3,4-d]pyrimidines as novel mitogen-activated protein kinase kinase 3 (MKK3) inhibitors.DOI 10.1016/j.bmc.2024.117674Drug-drug conjugates of MEK and Akt inhibitors for RAS-mutant cancers.DOI 10.1016/j.bmc.2024.117870FDA-approved small molecule kinase inhibitors for cancer treatment (2001-2015): Medical indication, structural optimization, and binding mode Part I.DOI 10.1016/j.bmc.2024.117980Ringing medicinal chemistry: The importance of 3-membered rings in drug discovery.DOI 10.1016/j.ejmech.2023.116101Development of potent and selective ULK1/2 inhibitors based on 7-azaindole scaffold with favorable in vivo properties.DOI 10.1021/acs.jmedchem.3c02129An Improved PDE6D Inhibitor Combines with Sildenafil To Inhibit <i>KRAS</i> Mutant Cancer Cell Growth.

Documentation & Compliance Facts

Compliance Facts

Shipment review: Required

Documentation available by request

Certificate of Analysis (COA): By request

Supplier Safety Data Sheet (SDS): By request

Purity and pack size confirmation: By request

Availability and lead time review: Confirmed by RFQ

Shipment documentation review: By request

For supplier-issued documentation by request, use the RFQ actions on this page.Review preliminary safety reference

What happens after RFQ

  1. 1We review the CAS identity, quantity, and documentation request.
  2. 2We check sourcing options, supplier availability, COA/SDS, purity, pack size, and lead time.
  3. 3We review destination and shipment documentation needs when applicable.
  4. 4We follow up with a quotation or clarification request.

Text Reference Cues

Show non-linked catalog cues

Non-public related references

Trametinib Dimethyl SulfoxideCAS 1187431-43-1
3-Cyclopropyl-1-(2-fluoro-4-iodophenyl)-5-hydroxy-6,8-dimethylpyrido(2,3-d)pyrimidine-2,4,7(1H,3H,8H)-trioneCAS 871700-24-2

Non-public references are shown as text only and do not imply equivalence, availability, or shared use.

Catalog navigation

Related Catalog Entries

Other public CAS pages in this catalog. These links support navigation across additional intermediates and do not imply equivalence, availability, or shared use.

CAS 571190-30-2PalbociclibCAS 120685-11-2MidostaurinCAS 62996-74-1StaurosporineCAS 1187431-43-1Trametinib Dimethyl SulfoxideCAS 871700-24-23-Cyclopropyl-1-(2-fluoro-4-iodophenyl)-5-hydroxy-6,8-dimethylpyrido(2,3-d)pyrimidine-2,4,7(1H,3H,8H)-trioneCAS 872511-34-7InfigratinibCAS 1002310-00-0Tert-butyl 1-(2-chloro-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)ethylcarbamateCAS 1005174-17-3(E)-3-(2-Propyl-6-(trifluoromethyl)pyridin-3-yl)acrylic acidCAS 1018125-49-92-(3-Cyclopropyl-6-ethyl-4-(trifluoromethyl)-1H-pyrazolo[3,4-b]pyridin-1-yl)acetic acidCAS 1018128-07-8Isopropyl 4-chloro-2-methylquinoline-6-carboxylate

RFQ questions for CAS 871700-17-3

What are the key identifiers for Trametinib (CAS 871700-17-3)?

Trametinib is identified by CAS 871700-17-3, with molecular formula C26H23FIN5O4, molecular weight 615.4, InChIKey LIRYPHYGHXZJBZ-UHFFFAOYSA-N.

Does CAS 871700-17-3 have reported biological target evidence?

ChEMBL contains qualifying experimental assay evidence associated with Dual specificity mitogen-activated protein kinase kinase 1, Dual specificity mitogen-activated protein kinase kinase 2, Mitogen-activated protein kinase 1, Tyrosine-protein kinase ABL1, Aurora kinase A. These records do not establish therapeutic efficacy or clinical use.

Can I request a COA for CAS 871700-17-3?

Yes. Submit an RFQ and specify COA requirements. Lot-specific COA depends on supplier confirmation.

Can I request supplier SDS for Trametinib?

Yes. Supplier SDS can be requested through the RFQ workflow before handling, storage, shipment, or procurement decisions.

Is CAS 871700-17-3 available for quotation?

Availability, pack size, lead time, and pricing are confirmed through RFQ.

Can MolGraph support bulk sourcing or custom synthesis review?

Submit the CAS number, quantity, purity requirement, and destination country for sourcing review.